Systemic effects of local allergic disease

Slides:



Advertisements
Similar presentations
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Advertisements

Monoclonal antibodies and fusion proteins in medicine
Allergen immunotherapy: A practice parameter third update
Different expression of cytokine and membrane molecules by circulating lymphocytes on acute mental stress in patients with atopic dermatitis in comparison.
The epidemiology of the atopic child
Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials  Javier Dibildox,
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Road signs guiding leukocytes along the inflammation superhighway
Allergic Rhinitis and Its Impact on Asthma
Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema  Dagmar Simon, MD, Jennifer Wittwer, MD, Ganna Kostylina,
The Editors' Choice Journal of Allergy and Clinical Immunology
Mast cell–T cell interactions
Biologics in patients with skin diseases
Role of platelets in allergic airway inflammation
Is 9 more than 2 also in allergic airway inflammation?
Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials  Javier Dibildox,
Thomas F. Tedder, PhD, Takashi Matsushita, MD, PhD 
Histamine in the immune regulation of allergic inflammation
The enigma of IgE+ B-cell memory in human subjects
Half-life of IgE in serum and skin: Consequences for anti-IgE therapy in patients with allergic disease  Monica G. Lawrence, MD, Judith A. Woodfolk, MBChB,
Yuichi Teraki, MD, Aika Sakurai, MD, Seiichi Izaki, MD 
The National Biome Initiative: An allergy perspective
Rhinitis and asthma: Evidence for respiratory system integration
The impact of allergic rhinitis on bronchial asthma
Cellular and mediator responses twenty-four hours after local endobronchial allergen challenge of asthmatic airways  Anthony J. Frew, MD, Johanne St-Pierre,
Inflammatory health effects of indoor and outdoor particulate matter
Mast cell activation syndrome: Proposed diagnostic criteria
Distinguishing severe asthma phenotypes
Possible role of TH17 cells in the pathogenesis of Stevens-Johnson syndrome and toxic epidermal necrolysis  Yuichi Teraki, MD, Misaki Kawabe, MD, Seiichi.
A review of the current guidelines for allergic rhinitis and asthma
Pathophysiology of the inflammatory response
Volume 37, Issue 2, Pages (August 2012)
Basophils and eosinophils in allergic rhinitis
Biosimilars and drug development in allergic and immunologic diseases
Recruitment of T cells to the lung in response to antigen challenge
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Costimulatory molecules in the developing human gastrointestinal tract: A pathway for fetal allergen priming  Catherine A. Jones, PhD, Gillian H.S. Vance,
What is an “eosinophilic phenotype” of asthma?
Autophagy: Nobel Prize 2016 and allergy and asthma research
Changes in regulatory B-cell levels in bone marrow, blood, and sputum of patients with asthma following inhaled allergen challenge  John-Paul Oliveria,
Mechanisms of eosinophil-associated inflammation
Pathogenesis of allergic rhinitis
Lymphoid neogenesis in the giant papillae of patients with chronic allergic conjunctivitis  Akira Matsuda, MD, PhD, Nobuyuki Ebihara, MD, PhD, Norihiko.
Chemokines and their receptors in allergic disease
Molecular pathology of allergic disease
Allergic rhinitis Journal of Allergy and Clinical Immunology
Peter J. Barnes, DM, DSc, FRCP 
Risk of oral food challenges
Bradykinin increases the in vivo expression of the CXC chemokine receptors CXCR1 and CXCR2 in patients with allergic rhinitis  Jane Eddleston, PhD, Sandra.
Molecular and cellular mechanisms of allergic disease
Increased adhesion to vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 of eosinophils from patients with asthma  Lena Håkansson,
Richard Enelow, MD, Dawn F. Baramki, BSN, Larry C. Borish, MD 
Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis  Toyoyuki Hanazawa, MD, PhD, Julio.
Corticosteroids in the treatment of pediatric allergic rhinitis
Anticonvulsant-induced toxic epidermal necrolysis: Monitoring the immunologic response  Laura Leyva, MD, PhDa, Maria José Torres, MD, PhDa, Sinforiano.
Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways  Gert-Jan Braunstahl, MDa, b, Shelley.
Alvaro A. Cruz, MD, Robert M
The Editors' Choice Journal of Allergy and Clinical Immunology
Abnormalities of cell and mediator levels in bronchoalveolar lavage fluid of patients with mild asthma  Sally E. Wenzel, MD  Journal of Allergy and Clinical.
10. Drug allergy Journal of Allergy and Clinical Immunology
IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: Effect of immunotherapy  Kayhan T. Nouri-Aria, PhD, FRCPath, Charles.
Update on risk factors for food allergy
Immune pathomechanism of drug hypersensitivity reactions
Dendritic cells in nasal mucosa of subjects with different allergic sensitizations  Susanne M. Reinartz, MD, Joost van Tongeren, MD, Danielle van Egmond,
Adipose tissue, adipokines, and inflammation
News & Notes Journal of Allergy and Clinical Immunology
Eosinophilic gastrointestinal disorders (EGID)
Systemic responses after bronchial aspirin challenge in sensitive patients with asthma  Joanna S. Makowska, MD, PhD, Janina Grzegorczyk, PhD, Barbara Bienkiewicz,
Unique mechanistic features of allergic rhinitis
Advances in mechanisms of allergic disease in 2016
Presentation transcript:

Systemic effects of local allergic disease Alkis Togias, MD  Journal of Allergy and Clinical Immunology  Volume 113, Issue 1, Pages S8-S14 (January 2004) DOI: 10.1016/j.jaci.2003.09.051

FIG 1 Expression of endothelial adhesion molecules (VCAM-1, ICAM-1, and E-selectin) on bronchial muco-sal blood vessels after nasal allergen challenge. Levels were significantly increased in patients with allergic rhinitis compared with baseline values and with values seen in control subjects. CD-31 is a marker for endothelial cells. Adapted from Braunstahl GJ et al. J Allergy Clin Immunol 2001;107:469-76. Journal of Allergy and Clinical Immunology 2004 113, S8-S14DOI: (10.1016/j.jaci.2003.09.051)

FIG 2 Diagrammatic presentation of possible pathways involved in the development of distant inflammation (in Tissue 2) after a localized allergic reaction (in Tissue 1). As a result of the allergic reaction in Tissue 1, increased expression of adhesion molecules at the postcapillary venules can lead to activation of circulating leukocytes which, in turn, may home in distant tissues (Tissue 2). In addition, humoral factors deriving from the original reaction circulate in the blood and may affect Tissue 2. Antigen-presenting cells transport allergens to lymphoid organs and present them to T-lymphocytes. T cells are, thus, activated and enter the circulation. These cells will home at the original allergic reaction site, but could also home in the bone marrow or in other tissues (Tissue 2). Bone marrow leukocyte precursor cells can also become activated and begin to circulate, either because of cytokines from newly arrived lymphocytes or because of circulating humors. Journal of Allergy and Clinical Immunology 2004 113, S8-S14DOI: (10.1016/j.jaci.2003.09.051)